Search

Your search keyword '"Houria Hendel-Chavez"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Houria Hendel-Chavez" Remove constraint Author: "Houria Hendel-Chavez" Search Limiters Full Text Remove constraint Search Limiters: Full Text
Sorry, I don't understand your search. ×
36 results on '"Houria Hendel-Chavez"'

Search Results

1. Frequent detection of IFN-gamma -producing memory effector and effector T cells in patients with progressive multifocal leukoencephalopathy

2. Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies

3. Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy

4. Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy.

5. CD25 appears non essential for human peripheral T(reg) maintenance in vivo.

6. Resting regulatory CD4 T cells: a site of HIV persistence in patients on long-term effective antiretroviral therapy.

7. Increased Production of B-Cell Activating Cytokines and Altered Peripheral B-Cell Subset Distribution during HIV-Related Classical Hodgkin Lymphoma

8. Heterospecific Immunity Help to Sustain an Effective BK-virus Immune Response and Prevent BK-virus-associated Nephropathy

9. Increased Production of B-Cell Activating Cytokines and Altered Peripheral B-Cell Subset Distribution during HIV-Related Classical Hodgkin Lymphoma

10. Prospective evaluation of blood Epstein-Barr virus DNA load and antibody profile in HIV-related non-Hodgkin lymphomas

11. Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy

12. Hepatitis C virus or hepatitis B virus coinfection and lymphoma risk in people living with HIV

13. Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era

14. High Risk Features Contrast With Favorable Outcomes in HIV-associated Hodgkin Lymphoma in the Modern cART Era, ANRS CO16 LYMPHOVIR Cohort

15. Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era

16. Refractory T-Cell Anergy and Rapidly Fatal Progressive Multifocal Leukoencephalopathy After Prolonged CTLA4 Therapy

17. Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study

18. Use of Whole-Blood Transcriptomic Profiling to Highlight Several Pathophysiologic Pathways Associated With Response to Rituximab in Patients With Rheumatoid Arthritis: Data From a Randomized, Controlled, Open-Label Trial

19. CCL19, a B Cell Chemokine, Is Related to the Decrease of Blood Memory B Cells and Predicts the Clinical Response to Rituximab in Patients With Rheumatoid Arthritis

20. Characteristics of B-Cell Lymphomas in HIV/HCV-Coinfected Patients During the Combined Antiretroviral Therapy Era

21. Immunological Hallmarks of JC Virus Replication in Multiple Sclerosis Patients on Long-Term Natalizumab Therapy

22. Additional file 1: Table S1. of Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis

23. Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis

24. Residual HIV-1 replication may impact immune recovery in patients on first-line lopinavir/ritonavir monotherapy

25. Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study

26. Progressive contraction of the latent HIV reservoir around a core of less-differentiated CD4+ memory T Cells

27. Efficacy of Recombinant Human Interleukin 7 in a Patient With Severe Lymphopenia-Related Progressive Multifocal Leukoencephalopathy

28. Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis

29. B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: a six-month, national, multicenter, open-label study

30. CD25 Appears Non Essential for Human Peripheral Treg Maintenance In Vivo

31. Lack of evidence for prolonged double-long terminal repeat episomal HIV DNA stability in vivo

32. Characteristics and Outcome of HIV Associated Classical Hodgkin's Lymphoma Among 68 Patients Included in the French ANRS CO16 Lymphovir Cohort Study

33. Characteristics and Outcome Among 116 Patients with HIV Associated Lymphoma Included in the French ANRS CO16 Lymphovir Cohort Study

34. High Frequency of Marginal Zone Lymphomas Among Patients Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus - ANRS CO16 LYMPHOVIR Cohort Study

35. Resting Regulatory CD4 T Cells: A Site of HIV Persistence in Patients on Long-Term Effective Antiretroviral Therapy

36. Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren’s syndrome: results of the BELISS study

Catalog

Books, media, physical & digital resources